Tag: Safety

Splash risks, droplet dispersal during instrument reprocessing

Editor's Note This pilot project, by epidemiologist Cori L. Ofstead, MSPH, and colleagues finds that routine reprocessing activities generate substantial splashing and droplet dispersal, and that currently recommended items of personal protective equipment (PPE) do not adequately protect personnel from exposure. The researchers found that: Droplets were generated during every…

Read More

By: Judy Mathias
February 14, 2022
Share

The Joint Commission begins surveying for COVID-19 vaccinations in 24 states

Editor's Note As of February 14, The Joint Commission began surveying to the COVID-19 vaccination requirements in the 24 states that were not previously subject to the Centers for Medicare and Medicaid Services (CMS) “Omnibus COVID-19 Health Care Staff Vaccination” interim final rule. Healthcare organizations in these 24 states must…

Read More

By: Judy Mathias
February 14, 2022
Share

Study: Nearly a third of older adults developed new medical conditions after COVID-19

Editor's Note In this study, published by the British Medical Journal, 32% of individuals, 65 years and older, who were infected with COVID-19 developed at least one new medical condition in the months after the initial infection, the February 11 Becker’s Hospital Review reports. This 32% was 11% higher than…

Read More

By: Tarsilla Moura
February 14, 2022
Share

Vaccination rates and new COVID-19 infections by US county

Editor's Note This study led by researchers at the University of Cincinnati, finds that areas with low vaccination rates experienced a more intense surge of new cases during the third wave of the COVID-19 pandemic, primarily driven by the Delta variant. In the analysis, COVID-19 infections per 100,000 people during…

Read More

By: Judy Mathias
February 10, 2022
Share

The Joint Commission adds requirements, expands review process for PSCs

Editor's Note The Joint Commission announced on February 9 that it will add requirements and expand the review process to 2-days for Primary Stroke Centers (PSCs) that provide mechanical thrombectomy (MT) and are seeking advanced certification or recertification, effective July 1, 2022. The additional tracer time and requirements will help…

Read More

By: Judy Mathias
February 10, 2022
Share

Healthcare professionals can help combat vaccination hesitancy

  Editor's Note A Centers for Disease Control and Prevention (CDC) national survey analysis found that a recommendation from a healthcare provider may help increase COVID-19 vaccination rates, according to a February 8 report in JAMA. The survey, analyzed in the December 17, 2021, Morbidity and Mortality Weekly Report, titled…

Read More

By: Tarsilla Moura
February 10, 2022
Share

New inhaled vaccine delivers broad protection against COVID-19, variants

Editor's Note In this study, Canadian researchers at McMaster University (Hamilton, Ontario) confirm that their newly developed inhaled form of COVID-19 vaccine provides long-lasting protection against the original strain of SARS-Cov-2 and variants of concern. The researchers compared two types of adenovirus platforms for the vaccine. The adenoviruses serve as…

Read More

By: Judy Mathias
February 10, 2022
Share

Amazon expands telehealth services

Editor's Note Amazon announced on February 8 that it is expanding its telehealth service, Amazon Care, nationwide. Previously, it was available only to employees and their families in and around its Seattle headquarters. Amazon also is expanding its in-person care services to more than 20 new cities this year. When…

Read More

By: Judy Mathias
February 10, 2022
Share

Vaccine effectiveness against COVID-19 during 9 months after second vaccination

Editor's Note This study by researchers at Umea University in Sweden finds a progressive waning in vaccine effectiveness against COVID-19 of any severity during the first 9 months after the second vaccination, with the rate of waning differing by vaccine type Analyzing the total population of Sweden, vaccine effectiveness was…

Read More

By: Judy Mathias
February 8, 2022
Share

FDA: Class I recall of Empowered Diagnostics COVID-19 tests

Editor's Note The Food and Drug Administration (FDA) on January 28 identified the recall by Empowered Diagnostics (Pompano Beach, Florida) of its CovClear COVID-19 Rapid Antigen Test and ImmunoPass COVID-19 Neutralizing Antibody Rapid Test as Class I, the most serious. Empowered Diagnostics distributed these tests with labeling indicating they were…

Read More

By: Judy Mathias
February 8, 2022
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat